New pharma company

share buybacks

Announced during or since

tax bill passage

AbbVie

$10.0b

Pfizer

$10.0

Merck

$10.0

Amgen

$10.0

Celgene

$5.0

Allergan

$2.0

Baxter

$1.5

Cardinal

$1.0

Vertex

$500m

$50.0b

Total

New pharma company share buybacks

Announced during or since

tax bill passage

AbbVie

$10.0b

Pfizer

$10.0

Merck

$10.0

Amgen

$10.0

Celgene

$5.0

Allergan

$2.0

Baxter

$1.5

Cardinal

$1.0

Vertex

$500m

$50.0b

Total

New pharma company share buybacks

Announced during or since tax bill passage

AbbVie

$10.0b

Pfizer

$10.0

Merck

$10.0

Amgen

$10.0

Celgene

$5.0

Allergan

$2.0

Baxter

$1.5

Cardinal

$1.0

Vertex

$500m

$50.0b

Total

New pharma company share buybacks

Announced during or since tax bill passage

AbbVie

$10.0b

Pfizer

$10.0

Merck

$10.0

Amgen

$10.0

Celgene

$5.0

Allergan

$2.0

Baxter

$1.5

Cardinal

$1.0

Vertex

$500m

$50.0b

Total

New pharma company share buybacks

Announced during or since tax bill passage

AbbVie

$10.0b

Pfizer

$10.0

Merck

$10.0

Amgen

$10.0

Celgene

$5.0

Allergan

$2.0

Baxter

$1.5

Cardinal

$1.0

Vertex

$500m

$50.0b

Total